CLXT Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 2.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Calyxt Share Price & Price History
Current Price: $6.30
Price Change: +0.30 (1.20%)
As of 05/31/2023 01:00 AM ET
Calyxt Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 6/1/2023 | Rory B Riggs | CEO | Buy | 200 | $157.50 | $31,500.00 | 230,892 |  |
Calyxt Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 5/6/2022 | Nikko Asset Management Americas Inc. | 1,099,623 | $1.16M | 0.0% | -17.1% | 2.571% |  |
| 4/27/2022 | Sumitomo Mitsui Trust Holdings Inc. | 1,099,623 | $1.14M | 0.0% | -17.1% | 2.571% | |
| 2/8/2022 | Nikko Asset Management Americas Inc. | 1,326,256 | $2.69M | 0.0% | -31.3% | 3.444% | |
| 2/2/2022 | Sumitomo Mitsui Trust Holdings Inc. | 1,326,256 | $2.83M | 0.0% | -31.3% | 3.444% | |
| 1/24/2022 | Regents of The University of California | 501,798 | $1.07M | 0.1% | N/A | 1.303% | |
| 11/16/2021 | Two Sigma Advisers LP | 131,800 | $0.44M | 0.0% | +708.6% | 0.342% | |
| 11/16/2021 | Uniplan Investment Counsel Inc. | 521,553 | $1.76M | 0.1% | -0.6% | 1.354% | |
| 11/15/2021 | Marshall Wace LLP | 63,479 | $0.22M | 0.0% | +34.7% | 0.165% | |
| 11/15/2021 | First Manhattan Co. | 16,000 | $53K | 0.0% | +100.0% | 0.042% | |
| 11/12/2021 | Renaissance Technologies LLC | 104,213 | $0.35M | 0.0% | -62.4% | 0.271% | |
| 11/12/2021 | Oppenheimer & Co. Inc. | 19,259 | $65K | 0.0% | -22.1% | 0.050% | |
| 11/12/2021 | Connor Clark & Lunn Investment Management Ltd. | 24,798 | $84K | 0.0% | +85.0% | 0.064% | |
| 11/10/2021 | KBC Group NV | 45,198 | $0.18M | 0.0% | +100.0% | 0.117% | |
| 11/9/2021 | Nikko Asset Management Americas Inc. | 1,930,098 | $6.27M | 0.0% | -24.0% | 5.012% | |
| 10/25/2021 | Sumitomo Mitsui Trust Holdings Inc. | 1,930,098 | $6.50M | 0.0% | -24.0% | 5.179% | |
| 8/17/2021 | Millennium Management LLC | 198,142 | $0.80M | 0.0% | N/A | 0.532% | |
| 8/17/2021 | Price T Rowe Associates Inc. MD | 28,100 | $0.11M | 0.0% | -26.1% | 0.075% | |
| 8/16/2021 | State Street Corp | 41,132 | $0.17M | 0.0% | -77.8% | 0.110% | |
| 8/16/2021 | Goldman Sachs Group Inc. | 43,728 | $0.18M | 0.0% | +120.2% | 0.117% | |
Data available starting January 2016
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company to enhance the quality of alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota.
Read More on Calyxt
Volume
254,056 shs
Average Volume
139,308 shs
Market Capitalization
$31.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.98
